Christopher Davis - Davis Advisors
Holding/activity history for Quest Diagnostics (DGX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 2,399,103 | 2.09 | Add 0.35% | 0.01 | $155.25 |
| 2024 Q2 | 2,390,828 | 1.85 | Add 0.41% | 0.01 | $136.88 |
| 2024 Q1 | 2,381,163 | 1.78 | Reduce 10.70% | 0.21 | $133.11 |
| 2023 Q4 | 2,666,564 | 2.08 | Add 59.89% | 0.78 | $137.88 |
| 2023 Q3 | 1,667,698 | 1.27 | Add 10.16% | 0.12 | $121.86 |
| 2023 Q2 | 1,513,888 | 1.30 | Reduce 0.32% | 0.00 | $140.56 |
| 2023 Q1 | 1,518,752 | 1.42 | Reduce 17.27% | 0.30 | $141.48 |
| 2022 Q4 | 1,835,823 | 1.95 | Reduce 1.89% | 0.04 | $156.44 |
| 2022 Q3 | 1,871,160 | 1.63 | Reduce 0.99% | 0.02 | $122.69 |
| 2022 Q2 | 1,889,815 | 1.61 | Reduce 2.94% | 0.05 | $132.98 |
| 2022 Q1 | 1,947,058 | 1.35 | Reduce 2.97% | 0.04 | $136.86 |
| 2021 Q4 | 2,006,628 | 1.61 | Reduce 26.84% | 0.59 | $173.01 |
| 2021 Q3 | 2,742,956 | 1.84 | Reduce 2.58% | 0.05 | $145.31 |
| 2021 Q2 | 2,815,614 | 1.53 | Add 1.35% | 0.02 | $131.97 |
| 2021 Q1 | 2,778,106 | 1.56 | Reduce 5.12% | 0.08 | $128.34 |
| 2020 Q4 | 2,927,958 | 1.68 | Reduce 21.84% | 0.47 | $119.17 |
| 2020 Q3 | 3,746,313 | 2.39 | Reduce 3.31% | 0.08 | $114.49 |
| 2020 Q2 | 3,874,574 | 2.55 | Add 0.20% | 0.01 | $113.96 |
| 2020 Q1 | 3,866,858 | 2.10 | Reduce 0.96% | 0.02 | $80.30 |
| 2019 Q4 | 3,904,487 | 1.99 | $106.79 |